Urology · Saginaw, MI
NPI
1982697074
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1117 S Washington Ave
Saginaw, MI, 48601
Phone (989) 791-4020
Groups this clinician bills Medicare through
Medicare paid, 2024
$601K
11,665 services
Medicare patients, 2024
1,160
Average age 75
Drug cost, 2024
$3.6M
7,883 prescriptions
Company payments, 2025
$2,449
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aditya D Bulusu was code J1952 (leuprolide injectable, camcevi, 1 mg), 1,638 times for 25 patients. In total Aditya D Bulusu billed 11,665 services in 77 codes, and Medicare paid $601K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 1,638 | 25 | $44.87 | $74K |
| 99214 Office E&M - Established | Office | 1,349 | 886 | $79.64 | $107K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,325 | 921 | $11.58 | $15K |
| 51798 Ultrasound - Nonspecific | Office | 782 | 598 | $7.28 | $5,692 |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 442 | 13 | $2.19 | $969 |
| 81002 Clinical Chemistry | Office | 361 | 308 | $3.36 | $1,215 |
| 99213 Office E&M - Established | Office | 311 | 256 | $61.39 | $19K |
| 82570 Clinical Chemistry | Office | 276 | 244 | $5.01 | $1,383 |
| 52000 Cystourethroscopy | Office | 242 | 218 | $169.32 | $41K |
| 99204 Office E&M - New | Office | 196 | 196 | $105.40 | $21K |
| 52442 Cystourethroscopy | Office | 180 | 30 | $611.42 | $110K |
| 99221 Hospital E&M - Initial | Facility | 102 | 94 | $61.11 | $6,233 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 88 | 12 | $137.91 | $12K |
| 76872 Ultrasound - Nonspecific | Office | 86 | 84 | $87.95 | $7,564 |
| 96372 Injection Administration | Office | 69 | 11 | $9.11 | $629 |
By year: 2022 $593K for 11,171 services; 2023 $623K for 10,477 services; 2024 $601K for 11,665 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 361 | 308 | $3.36 | $1,215 |
| 82570 Clinical Chemistry | 276 | 244 | $5.01 | $1,383 |
Medicare prescription drug claims, 2024
In 2024, the drug Aditya D Bulusu prescribed most often to Medicare patients was Tamsulosin Hcl, with 2,002 prescriptions and refills. In total Aditya D Bulusu wrote 7,883 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 2,002 | 5,412 | 723 | $48K |
| Ciprofloxacin Hcl Generic | 768 | 768 | 548 | $2,465 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 448 | 1,156 | 170 | $15K |
| Finasteride Generic | 435 | 1,247 | 136 | $9,852 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 426 | 457 | 387 | $3,813 |
| Cephalexin Generic | 379 | 622 | 231 | $5,907 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 303 | 406 | 249 | $1,325 |
| Myrbetriq Mirabegron | 276 | 534 | 94 | $232K |
| Trospium Chloride Generic | 265 | 653 | 129 | $28K |
| Celecoxib Generic | 249 | 249 | 230 | $1,343 |
| Dutasteride Generic | 226 | 604 | 80 | $9,415 |
| Xtandi Enzalutamide | 204 | 204 | 23 | $2.9M |
| Levofloxacin Generic | 198 | 198 | 158 | $1,002 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 141 | 397 | 59 | $4,771 |
| Bethanechol Chloride Generic | 83 | 181 | 32 | $7,069 |
Brand drugs: 765 claims; generic drugs: 7,104 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aditya D Bulusu $2,449 ($2,449 in general payments such as food, travel and fees) from 30 companies. The largest payer was Procept Biorobotics Corporation with $782.
| Company | Payments | Amount |
|---|---|---|
| Procept Biorobotics Corporation PRCT | 1 | $782 |
| Janssen Biotech, Inc. JNJ | 11 | $273 |
| Sumitomo Pharma America, Inc. 4506.T | 10 | $139 |
| Ferring Pharmaceuticals Inc. | 5 | $119 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $106 |
| Myriad Genetic Laboratories, Inc. MYGN | 4 | $94.91 |
| Teleflex LLC TFX | 4 | $88.08 |
| Astellas Pharma US Inc 4503.T | 4 | $83.42 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $70.88 |
| Medtronic, Inc. MDT | 3 | $70.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.